Background Bariatric surgery, incretin-based therapy (gluca- dure to treat T2DM in class I obese patients. It is also superior gon-like peptide-1 analogues), and sodium-glucose co-trans- to advance medical treatment modalities such as GLP-1 ana- porter 2 (SGLT2) inhibitors have antidiabetic properties in logues and SGLT2 inhibitors. morbidly obese patients. However, their comparative efficacy . . in treating type 2 diabetes mellitus (T2DM) in class I obese Keywords Bariatric surgery Class I obesity GLP-1 patients specifically in Indian has not been studied yet. This analogues SGLT2 inhibitor study evaluates and compares the efficacy and side effect of surgical and advanced medical management of T2DM in class I obese patients. Introduction Methods T2DM patients with body mass index ranging from 30 to 35 kg/m and with a median duration of 3 years and Bariatric surgery has emerged as the preferred modality for HbA1c level >7.5% were recruited for the study. Selection of treatment of type 2 diabetes mellitus (T2DM) in morbidly treatment option that is bariatric surgery, GLP-1 analogues obese. Most patients are able to downgrade their medical man- and SGLT2 inhibitor, was kept on patient’schoice. Each agement with this modality and some can get rid of all med- group had
Obesity Surgery – Springer Journals
Published: Jun 11, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud